In a time when COAs are more nuanced, critical and complex than ever, researchers can turn to best practices to move forward ...

The evolution of clinical trials shows that although much has changed, several things remain the same. When a patient expresses interest in a trial, they complete an informed consent process, and ...

The clinical trial ecosystem is entering a phase of consolidation and reinvention driven by the collapse of boundaries between functions, data, and even companies themselves.

Traditional trial start-up workflows often follow a sequential path, from feasibility to contracting, then regulatory ...

TransCelerate BioPharma (TransCelerate), a nonprofit organization dedicated to improving the health of people around the world by accelerating and simplifying clinical research, today announced the ...

Together, Risklick and Citeline deliver an integrated, intelligent protocol development experience that combines smart ...

Innovation in ophthalmology is often measured by what reaches the clinic—but the path to those breakthroughs begins much ...

There is a wealth of data, reviews, articles, and regulatory guidance on how to conduct clinical trials to take a biosimilar from conception to market. However, there is minimal literature describing ...

"We are excited to see Pfizer advancing MesoC2 into clinical development rapidly, highlighting the potential of Nona's Harbour Mice® and integrated ADC platforms to deliver innovative cancer therapies ...